Tag: #Global Trends

As part of its overall $55 billion U.S. investment plan, Johnson & Johnson (J&J) has announced the construction of a... Read more

President Donald Trump is pushing forward with his Most Favored Nation (MFN) plan to reduce prescription drug costs, but the... Read more

The European Commission has officially granted marketing authorization for Gotenfia, a golimumab biosimilar developed through the partnership between Bio-Thera and... Read more

French pharmaceutical giant Sanofi has announced a major leadership transition, with Belén Garijo set to take over as CEO, replacing... Read more

Chinese market regulators have recently ordered all infant formula producers to conduct mandatory testing for cereulide toxins. This directive follows... Read more

The U.S. Food and Drug Administration (FDA) has issued a refusal-to-file (RTF) letter regarding Moderna’s next-generation mRNA flu vaccine (mRNA-1010),... Read more

AbbVie has struck a pivotal agreement with the U.S. administration, signaling a major evolution in healthcare policy where domestic production... Read more

Takeda has entered into a multi-year strategic partnership with Iambic to utilize artificial intelligence in advancing small molecule drug programs.... Read more

AstraZeneca concluded fiscal year 2025 with total revenue reaching $58.7 billion, an 8% increase compared to the previous year. The... Read more